Vaping – A Beneficial Alternative to Traditional Cigarettes or an Unexplored Danger?
DOI:
https://doi.org/10.12775/QS.2025.37.57439Keywords
vaping, e-cigarettes, smoking, COPD, nicotine replacement therapyAbstract
The aim of this study is to assess the risks associated with e-cigarette use, particularly in the context of cardiovascular and respiratory health. In addition, the article addresses the social aspect of vaping as a significant challenge faced by national public health institutions, with a special focus on the prevalence of addiction among youth.
Methods:
We carried out a comprehensive review using PubMed and Google Scholar, with a primary focus on literature published within five to eight years. The searches were performed using “vaping”, “e-cigarettes”, “smoking”, “COPD”, “nicotine replacement therapy” and the names of its components as search terms to retrieve relevant articles. Furthermore, references cited in the selected articles were also included in the analysis.
Results:
The current evidence suggests that while e-cigarettes may pose a lower risk than traditional cigarettes, they are not risk-free. Dual use of cigarettes and e-cigarettes increases cardiovascular risk and is comparable to the risks associated with exclusive cigarette smoking. Studies suggest that long-term e-cigarette use may result in increased aortic stiffness, elevated heart rate, heightened risk of atherosclerosis and diminished lung function, increased airway resistance, especially in individuals with pre-existing conditions like asthma. Exposure to aerosolized chemicals present in e-liquids poses risks of chronic respiratory diseases.
Conclusions:
The precise impact of e-cigarette use on health needs further research and long-term observations. Particular concern arises from the unregulated composition of e-liquids, which are gaining popularity among youth, thereby promoting early nicotine addiction and normalizing the use of tobacco products. Efforts to regulate the composition of e-liquids and the use of harmful additives are crucial to mitigate the potential health risks associated with vaping.
References
Besaratinia A, Tommasi S. Vaping epidemic: challenges and opportunities. Cancer Causes Control. 2020;31(7):663–667. https://doi.org/10.1007/s10552-020-01307-y
Jenssen BP, Walley SC. E-cigarettes and similar devices. Pediatrics. 2019;143(2):e20183652. https://doi.org/10.1542/peds.2018-3652
Dinardo P, Rome ES. Vaping: The new wave of nicotine addiction. Cleveland Clinic Journal of Medicine. 2019;86(12):789–798. https://doi.org/10.3949/ccjm.86a.19118
Bold KW, Krishnan-Sarin S, Soney CM. E-Cigarette Use as a Potential Cardiovascular Disease Risk Behavior. Am Psychol. 2018;73(8):955–967. https://doi.org/10.1037/amp0000231
Institute for Prevention and Economic Analysis (IPAG). E-cigarettes: Current Data, Challenges, and Perspectives. 2024. Dostępne pod adresem: https://www.ipag.org.pl/Content/Uploaded/files/2024_02_01_Raport_IPAG_e-papierosy.pdf
Balwicka-Szczyrba M, Balwicki Ł, Hanke W, Miller M, Tyrańska-Fobke A. Strategic Recommendations for 2023–2027: Reducing the Use of Tobacco and Other Nicotine-Containing Products, Especially Among the Young Generation of Poles. 2023. Dostępne pod adresem: https://pan.pl/wp-content/uploads/2023/03/PolskieZdrowie2.0_II.3_REDUKCJA-UZYWANIA-TYTONIU-I-INNYCH-PRODUKTOW-ZAWIERAJACYCH-NIKOTYNE-SZCZEGOLNIE-WSROD-MLODEGO-POKOL.pdf
National Institute of Public Health – National Institute of Hygiene. Final Report: Assessment of the Epidemiological Situation Regarding the Use of Psychoactive Substances in Poland. 2020. Dostępne pod adresem: https://www.pzh.gov.pl/wp-content/uploads/2021/03/Raport-koncowy-26.11.2020-1-po-G-i-po-M.pdf
Office of the Commissioner for Children's Rights. E-cigarettes Are a Plague Among Children and Adolescents: The Commissioner Supports Restricting Their Sale. 2024. Dostępne pod adresem: https://brpd.gov.pl/2024/02/27/e-papierosy-to-plaga-wsrod-dzieci-i-mlodziezy-rzeczniczka-popiera-ograniczanie-ich-sprzedazy/
Solecka M. A Sales Ban May Not Be Enough. Medycyna Praktyczna. 2024. Dostępne pod adresem: https://www.mp.pl/pacjent/pediatria/aktualnosci/badania/343094,zakaz-sprzedazy-moze-nie-wystarczyc
Glasser A, Abudayyeh H, Cantrell J, Niaura R. Patterns of E-Cigarette use among youth and young adults: Review of the impact of E-Cigarettes on cigarette smoking. Nicotine & Tobacco Research. 2018;21(10):1320–1330. https://doi.org/10.1093/ntr/nty103
Medycyna Praktyczna. E-papierosy stały się nałogiem młodzieży. 2020. Dostępne pod adresem: https://www.mp.pl/pediatria/aktualnosci/255913,e-papierosy-staly-sie-nalogiem-mlodziezy,1
Marczylo T. How bad are e‐cigarettes? What can we learn from animal exposure models? The Journal of Physiology. 2020;598(22):5073–5089. https://doi.org/10.1113/jp278366
McAlinden KD, Eapen MS, Lu W, Sharma P, Sohal SS. The rise of electronic nicotine delivery systems and the emergence of electronic-cigarette-driven disease. AJP Lung Cellular and Molecular Physiology. 2020;315(5):L662–L672. https://doi.org/10.1152/ajplung.00389.2017
Behar RZ, Wang Y, Talbot P. Comparing the cytotoxicity of electronic cigarette fluids, aerosols and solvents. Tobacco Control. 2017;27(3):325–333. https://doi.org/10.1136/tobaccocontrol-2016-053472
Meo SA, Ansary MA, Barayan FR, Almusallam AS, Almehaid AM, Alarifi NS, Alsohaibani TA, Zia I. Electronic cigarettes: impact on lung function and fractional exhaled nitric oxide among healthy adults. American Journal of Men’s Health. 2018;13(1):1–7. https://doi.org/10.1177/1557988318806073
Lappas AS, Tzortzi AS, Konstantinidi EM, Teloniatis SI, Tzavara CK, Gennimata SA, Koulouris NG, Behrakis PK. Short-term respiratory effects of e-cigarettes in healthy individuals and smokers with asthma. Respirology. 2017;23(3):291–297. https://doi.org/10.1111/resp.13180
Glynos C, Bibli S, Katsaounou P, Pavlidou A, Magkou C, Karavana V, Topouzis S, Kalomenidis I, Zakynthinos S, Papapetropoulos A. Comparison of the effects of e-cigarette vapor with cigarette smoke on lung function and inflammation in mice. AJP Lung Cellular and Molecular Physiology. 2018; 315(5), L662–L672. https://doi.org/10.1152/ajplung.00389.2017
Campagna D, Amaradio MD, Sands MF, Polosa R. Respiratory infections and pneumonia: potential benefits of switching from smoking to vaping. Pneumonia. 2016;8(1):1–9. https://doi.org/10.1186/s41479-016-0001-2
Thirión-Romero I, Pérez-Padilla R, Zabert G, Barrientos-Gutiérrez I. Respiratory impact of electronic cigarettes and “low-risk” tobacco. Clinical and translational investigation. 2019;71:17-27. https://doi.org/10.24875/ric.18002616
Ali M, Khan K, Buch M, Ramirez MR, Sharma M, Patel S, Choudhury S, Anjum H, Khan A, Surani S. A case series of Vaping-Induced lung injury in a community hospital setting. Case Reports in Pulmonology. 2020;2020:1–7. https://doi.org/10.1155/2020/9631916
Smith ML, Gotway MB, Alexander LEC, Hariri LP. Vaping-related lung injury. Virchows Archiv. 2020;478(1):81–88. https://doi.org/10.1007/s00428-020-02943-0
Butt YM, Smith ML, Tazelaar HD, Vaszar LT, Swanson KL, Cecchini MJ, Boland JM, Bois MC, Boyum JH, Froemming AT, Khoor A, Mira-Avendano I, Patel A, Larsen BT. Pathology of Vaping-Associated lung injury. New England Journal of Medicine. 2019;381(18):1780–1781. https://doi.org/10.1056/nejmc1913069
Wold LE, Tarran R, Alexander LEC, Hamburg NM, Kheradmand F, St Helen G, Wu JC. Cardiopulmonary consequences of vaping in adolescents: a scientific statement from the American Heart Association. Circulation Research. 2022;131(3):E13–E25. https://doi.org/10.1161/res.0000000000000544
Tsai M, Byun MK, Shin J, Alexander LEC. Effects of e‐cigarettes and vaping devices on cardiac and pulmonary physiology. The Journal of Physiology. 2020;598(22):5039–5062. https://doi.org/10.1113/jp279754
Berlowitz JB, Xie W, Harlow AF, Hamburg NM, Blaha MJ, Bhatnagar A, Benjamin EJ, Stokes AC. E-Cigarette use and risk of cardiovascular disease: A longitudinal analysis of the PATH Study (2013–2019). Circulation. 2022;145(20):1557–1559. https://doi.org/10.1161/circulationaha.121.057369
Bała MM, Cedzyńska M, Balwicki Ł, Czajkowska-Malinowska M, Jankowska-Zduńczyk A, Jassem J, Korycińska D, Lewandowska D, Mejza F, Pazik J, Puścińska E, Szymański J, Zając J, Jankowski P. Guidelines for Treating Nicotine Addiction: Introduction and Summary of Recommendations. Medycyna Praktyczna. 2022. Dostępne pod adresem: https://www.mp.pl/pulmonologia/artykuly-wytyczne/inne/299775,wytyczne-leczenia-uzaleznienia-od-nikotyny-podsumowanie-zalecen,1
Zaczek R. Pharmacotherapy for Nicotine Addiction. Choroby Serca i Naczyń. 2017;14(4):214-216. Dostępne pod adresem: https://journals.viamedica.pl/choroby_serca_i_naczyn/article/download/56408/42408
Hartmann-Boyce J, Chepkin SC, Ye W, Bullen C, Lancaster T. Nicotine replacement therapy versus control for smoking cessation. Cochrane Library. 2019; 2019(1):1–101. https://doi.org/10.1002/14651858.cd000146.pub5
Rehan HS, Maini J, Hungin APS. Vaping versus smoking: A quest for efficacy and safety of e-cigarette. Current Drug Safety. 2018;13(2):92–101. https://doi.org/10.2174/1574886313666180227110556
Hajek P, Phillips-Waller A, Przulj D, Pesola F, Smith KM, Bisal N, Li J, Parrott S, Sasieni P, Dawkins L, Ross L, Goniewicz M, Wu Q, McRobbie HJ. A Randomized Trial of E-Cigarettes versus Nicotine-Replacement Therapy. New England Journal of Medicine. 2019;380(7):629–637. https://doi.org/10.1056/nejmoa1808779
Bullen C, Howe C, Laugesen M, McRobbie H, Parag V, Williman J, Walker N. Electronic cigarettes for smoking cessation: a randomised controlled trial. The Lancet. 2013;382(9905):1629–1637. https://doi.org/10.1016/s0140-6736(13)61842-5
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Paulina Błasiak, Aleksandra Ślusarska, Patryk Mikołajec, Barbara Bilecka, Jolanta Mędyk, Małgorzata Wirkijowska, Jakub Wirkijowski, Yauheniya Patarocha, Michał Rogulski, Ruslan Huk
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Stats
Number of views and downloads: 26
Number of citations: 0